News

Public · Published

Ducommun 3Q 2026: Revenue $227.02M, EPS $0.89 — 10-Q Summary

Ducommun reported third-quarter 2026 revenue of $227.02 million and diluted earnings per share of $0.89. Revenue increased year over year, and the company returned to net income from a prior-year loss. Higher commercial aerospace sales and manufacturing volume contributed to the improvement.

Published:

Updated:

What happened

Ducommun reported third-quarter 2026 revenue of $227.02 million and diluted earnings per share of $0.89. Revenue increased year over year, and the company returned to net income from a prior-year loss. Higher commercial aerospace sales and manufacturing volume contributed to the improvement.

Confirmed

Global impact / market context

The return to profit and higher revenue show that stronger commercial aerospace demand and factory volume translated into improved results. However, higher manufacturing costs in Structural Systems and increased selling, general and administrative expenses, taxes, and pension costs limited the benefit, so growth did not lift every business measure.

Analyst inference

Ducommun’s remaining performance obligations, meaning contracted work not yet recorded as revenue, totaled $1,286.2 million, with about 70% expected to become revenue in the next 12 months. That provides visibility, but actual results still depend on delivering orders and controlling production costs.

Analyst inference

What to watch

  1. Check whether commercial aerospace sales and manufacturing volume continue to support revenue growth, since these were identified as key drivers of the quarter’s improvement. Analyst inference
  2. Watch Structural Systems’ manufacturing costs and product mix, meaning the blend of work performed, because both weighed on segment operating income despite higher revenue. Analyst inference
  3. Compare future revenue with the expected recognition of about 70% of remaining performance obligations over the next 12 months, while noting that this is an expectation. Analyst inference

Evidence

  • Original source link unavailable